API
< Back to all clusters
[BUSINESS] · Brazil · 5 sources

started · updated

Oncoclínicas OPA suspended by court order

A federal court in São Paulo has issued an injunction suspending a decision by the Brazilian Securities Commission (CVM) that required the fund Josephina III to launch a mandatory tender offer (OPA) for Oncoclínicas.

The dispute centers on a 'poison pill' clause triggered when a shareholder exceeds a 15% stake. While the CVM determined that Josephina III must make an offer to other shareholders—estimated to be worth between R$ 12 billion and R$ 20 billion—the fund is contesting this obligation in court. Josephina III argues it is an existing shareholder exempt from the clause.

Following the judicial suspension, Oncoclínicas canceled an extraordinary general meeting scheduled for early November. The meeting had been called by funds linked to the manager Latache, which holds a 14% stake and would be a primary beneficiary of the tender offer. The meeting was intended to discuss the potential suspension of Josephina III’s shareholder rights.

Oncoclínicas stated it is not a party to the legal dispute between its shareholders but canceled the assembly due to the loss of its immediate legal basis.

Entities

Comissão de Valores Mobiliários · Josephina III · Latache · Oncoclínicas · São Paulo